Delivery Order SPE2DB20D3103-SPE2DB24FN8Z6
- Not listed
- This federal contract award, valued at $13,971.12, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 200-unit vials of the prescription drug Botox. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. This single-award IDC serves as the primary vehicle for...
- This federal contract award, valued at $3,492.78, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200 unit vials of Botox, a specialty medication. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
- This federal contract award, valued at $4,273.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 200-unit vials of Botox, a medical product, to support federal healthcare programs. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,642.60, is for the delivery of 200 unit vials of the medication Botox. It is a firm fixed-price Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen, valued at $999,999,999, to provide a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award, valued at $1,292.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 100 UNIT VIALS and is a Firm Fixed Price Delivery Order without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award, valued at $14,553.25, was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Defense Logistics Agency (DLA). The contract is for the delivery of 200-unit vials of Botox, a prescription pharmaceutical product. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,022.50, is for the delivery of 200-unit vials of Botox. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
- This federal contract award, valued at $58,213, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOTOX 200 unit vials and has a period of performance through September 2024. The award is a delivery order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award, valued at $8,731.95, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 200-unit vials of BOTOX, a pharmaceutical product, with a completion date of August 21, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,257.48 firm fixed-price delivery order is for the procurement of 200-unit vials of BOTOX, with a period of performance through January 28, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FN8Z6Delivery Order
This federal contract award, valued at $61,123.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract provides for the delivery of 200 unit vials of Botox to support the agency's medical supply requirements. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare systems, through its extensive supply chain and distribution capabilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.1k | 5/20/24 |